Serum Soluble B7-H3 Is a Prognostic Marker for Patients With NMIBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
PloS One
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Serum Soluble B7-H3 Is a Prognostic Marker for Patients With Non-Muscle-Invasive Bladder Cancer
PLoS ONE 2020 Dec 01;15(12)e0243379, T Azuma, Y Sato, T Ohno, M Azuma, H KumeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.